193 related articles for article (PubMed ID: 15291354)
41. The role of Bcl-2 in the pathogenesis of B chronic lymphocytic leukemia.
Schena M; Gottardi D; Ghia P; Larsson LG; Carlsson M; Nilsson K; Caligaris-Cappio F
Leuk Lymphoma; 1993 Oct; 11(3-4):173-9. PubMed ID: 8260892
[TBL] [Abstract][Full Text] [Related]
42. Survival patterns among lymphoma patients with a family history of lymphoma.
Anderson LA; Pfeiffer RM; Rapkin JS; Gridley G; Mellemkjaer L; Hemminki K; Björkholm M; Caporaso NE; Landgren O
J Clin Oncol; 2008 Oct; 26(30):4958-65. PubMed ID: 18606984
[TBL] [Abstract][Full Text] [Related]
43. c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin's lymphoma.
Aref S; Fouda M; El-Dosoky E; Menessy A; Mabed M; Saleeb M; Zalata K
Hematology; 2003 Jun; 8(3):183-90. PubMed ID: 12745652
[TBL] [Abstract][Full Text] [Related]
44. Very low levels of surface CD45 reflect CLL cell fragility, are inversely correlated with trisomy 12 and are associated with increased treatment-free survival.
Rizzo D; Lotay A; Gachard N; Marfak I; Faucher JL; Trimoreau F; Guérin E; Bordessoule D; Jaccard A; Feuillard J
Am J Hematol; 2013 Sep; 88(9):747-53. PubMed ID: 23733486
[TBL] [Abstract][Full Text] [Related]
45. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
46. Recurrent Cytogenetic Abnormalities in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.
Ma ES
Methods Mol Biol; 2017; 1541():279-293. PubMed ID: 27910030
[TBL] [Abstract][Full Text] [Related]
47. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
48. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.
van Lohuizen M; Verbeek S; Krimpenfort P; Domen J; Saris C; Radaszkiewicz T; Berns A
Cell; 1989 Feb; 56(4):673-82. PubMed ID: 2537153
[TBL] [Abstract][Full Text] [Related]
49. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies.
Jaffe ES; Zarate-Osorno A; Medeiros LJ
Semin Diagn Pathol; 1992 Nov; 9(4):297-303. PubMed ID: 1480852
[TBL] [Abstract][Full Text] [Related]
50. Low grade lymphomas in the elderly.
Alkan S; Karcher DS
Ann Clin Lab Sci; 1995; 25(3):218-27. PubMed ID: 7605103
[TBL] [Abstract][Full Text] [Related]
51. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.
Wessendorf S; Schwaenen C; Kohlhammer H; Kienle D; Wrobel G; Barth TF; Nessling M; Möller P; Döhner H; Lichter P; Bentz M
Oncogene; 2003 Mar; 22(9):1425-9. PubMed ID: 12618769
[TBL] [Abstract][Full Text] [Related]
52. Expression of the candidate MCT-1 oncogene in B- and T-cell lymphoid malignancies.
Shi B; Hsu HL; Evens AM; Gordon LI; Gartenhaus RB
Blood; 2003 Jul; 102(1):297-302. PubMed ID: 12637315
[TBL] [Abstract][Full Text] [Related]
53. Fcγ receptor polymorphisms and clinical efficacy of rituximab in non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Zhuang Y; Xu W; Shen Y; Li J
Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):347-52. PubMed ID: 21030347
[TBL] [Abstract][Full Text] [Related]
54. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
[TBL] [Abstract][Full Text] [Related]
55. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
Pekarsky Y; Santanam U; Cimmino A; Palamarchuk A; Efanov A; Maximov V; Volinia S; Alder H; Liu CG; Rassenti L; Calin GA; Hagan JP; Kipps T; Croce CM
Cancer Res; 2006 Dec; 66(24):11590-3. PubMed ID: 17178851
[TBL] [Abstract][Full Text] [Related]
56. Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas.
Thomázy VA; Luthra R; Uthman MO; Davies PJ; Medeiros LJ
J Mol Diagn; 2002 Nov; 4(4):201-8. PubMed ID: 12411587
[TBL] [Abstract][Full Text] [Related]
57. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
[TBL] [Abstract][Full Text] [Related]
58. Expression of DNA mismatch repair proteins in transformed non-Hodgkin's lymphoma: relationship to smoking.
Nandi S; Yu J; Burger AM; Reinert LS; Gartenhaus RB
Leuk Lymphoma; 2006 Sep; 47(9):1806-12. PubMed ID: 17064992
[TBL] [Abstract][Full Text] [Related]
59. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
[TBL] [Abstract][Full Text] [Related]
60. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]